IntelGenx reports positive results from study of new antihypertensive product
The results of the study indicate that the product is bioequivalent to a leading antihypertensive product brand. The product has been developed using IntelGenx’s multilayer ‘Versatab’ delivery technology.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.